These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5536903)

  • 1. Clinical observations on the therapeutic activity of flupentixol in the treatment of chronic schizophrenia.
    Dogliani P; Senini G; Bertuzzi F
    Arzneimittelforschung; 1970 Aug; 20(8):1126-40. PubMed ID: 5536903
    [No Abstract]   [Full Text] [Related]  

  • 2. Double blind study of clopenthixol and chlorpromazine in acute hospitalized schizophrenics.
    Kingstone E; Kolivakis T; Kossatz I
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):41-5. PubMed ID: 4909377
    [No Abstract]   [Full Text] [Related]  

  • 3. [Flupentixol (Fluanxol) in the treatment of apathic syndromes of schizophrenic origin].
    Strzyzewski W; Drogowski M
    Psychiatr Pol; 1971; 5(2):207-10. PubMed ID: 5576939
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-chloro-11(4'-methylpiperazino)-dibenzo-(b,f)(1,4)-oxazepine (Sum 3170), a new neuroleptic. Results of clinical testing].
    Angst J; Cornu F; Heimann H; Pöldinger W; Steiner H
    Arzneimittelforschung; 1970 Jul; 20(7):967-70. PubMed ID: 4248469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)].
    Gross H; Kaltenbäck E
    Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880
    [No Abstract]   [Full Text] [Related]  

  • 6. Thiothixene. Its range of therapeutic activity.
    Oliveros RT; Ban TA; Lehmann HE; Sterlin C; Saxena BM
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jan; 3(1):26-9. PubMed ID: 4909376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary study corncerning the treatment of chronic psychoses with Flupenthixol decanoate].
    Brasseur R
    Schweiz Rundsch Med Prax; 1971 Aug; 60(33):1107-13. PubMed ID: 5562153
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychopharmacology.
    Acta Psychiatr Scand Suppl; 1970; 217():53-8. PubMed ID: 4926229
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical psychometric evaluation of the effects of fluanxol, oxipertine and chlorpromazine in chronic schizophrenia. Comparative study].
    Predescu V; Ciurezu T; Romila A; Pirée S; Vianu I; Ionescu G; Braslă N; Florescu D; David E; Roman I; Zelingher R; Ivana D; Bucurică C; Damian N
    Neurol Psihiatr Neurochir; 1969; 14(5):389-400. PubMed ID: 5380156
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Parkinsonism with Tremarial (SJ-1977)].
    Kondo K; Takahashi Y; Yamamoto T; Matsumura K; Okuda Y
    No To Shinkei; 1967 Jul; 19(7):723-7. PubMed ID: 4384268
    [No Abstract]   [Full Text] [Related]  

  • 11. [Flupenthixol in the treatment of chronic schizophrenia].
    Arnone A; Parodi A; Masini A; Ambrosini G
    Riv Sper Freniatr Med Leg Alien Ment; 1970 Apr; 94(2):351-74. PubMed ID: 5484960
    [No Abstract]   [Full Text] [Related]  

  • 12. Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
    Serafetinides EA; Collins S; Clark ML
    J Nerv Ment Dis; 1972 Jan; 154(1):31-42. PubMed ID: 4550211
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
    Poeldinger W
    Arzneimittelforschung; 1967 Sep; 17(9):1133-5. PubMed ID: 5632287
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical evaluation of clopenthixol.
    Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
    Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of flupenthixol in the treatment and rehabilitation of chronic schizophrenia].
    Molcan J; Kukucová H; Koníková M
    Bratisl Lek Listy; 1971 Sep; 56(3):295-300. PubMed ID: 5114543
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences with Fluanxol-depot ampules in the treatment of patients with chronic psychoses].
    Schwalbe W
    Z Allgemeinmed; 1971 Dec; 47(36):1919-22. PubMed ID: 5142254
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical classification of neuroleptics. Critical study and current prospects].
    Kapsambelis V; Gekiere C; Ginestet D
    Encephale; 1990; 16(2):63-70. PubMed ID: 1972056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The problem of preclinical evaluation of psychotropic drugs].
    Tansella M; Dello Russo G
    Acta Neurol (Napoli); 1969; 24(6):877-91. PubMed ID: 5378619
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
    Dehnel LL; Vestre ND; Schiele BC
    Curr Ther Res Clin Exp; 1968 Apr; 10(4):169-76. PubMed ID: 4967871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.